Category: iRhythm Technologies Inc.Syndicate content

St. Jude-backed iRhythm Technologies raises another $16M for Zio wearable heart monitor

April 12, 2013 by Brad Perriello

iRhythm Technologies, which includes St. Jude Medical among its backers, lands a $16 million Series D round for its Zio wearable heart monitor.

iRhythm Zio wearable heart monitor

iRhythm Technologies said it closed a $16 million Series D round for its Zio wearable heart monitor, saying it plans to use the proceeds to further its commercial footprint and research & development efforts.

Led by Norwest Venture Partners, which added partner Casper de Clercq to iRhythm's board, the latest financing including contributions from existing backers New Leaf Ventures, Synergy Life Science Partners and Kaiser Permanente Ventures.

Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat

November 20, 2012 by MassDevice staff

Edwards Lifesciences is on track for mid-teens sales growth for its Sapien heart valve, according to a survey of 30 cardiologists by Leerink Swann analysts.

MassDevice.com Wall Street Beat

Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Mako Surgical preps $40M public offering | Wall Street Beat

November 14, 2012 by MassDevice staff

Medical device company Mako Surgical readies a public offering of more than 3 million shares worth more than $40 milion to help commercialize its Rio surgical robot.

MassDevice.com Wall Street Beat

Mako Surgical (NSDQ:MAKO) said it's planning to sell some 3 million shares of its own stock in an offering worth about $40 million.*

iRhythm appoints Kevin King president & CEO | Personnel Moves

August 1, 2012 by MassDevice staff

iRhythm Technologies takes on Kevin King as CEO, president and new board member.

fired/hired

 Kevin King appointed new CEO, president of iRythm technologies

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ACC 2012: Headlines from this week's American College of Cardiology conference

March 28, 2012 by MassDevice staff

Barclays weighs in on the TAVI trials, Medtronic touts pacing as an option for patients prone to fainting, iRhythm touts study results for Zio Patch cardiac rhythm monitoring and more from this week's American College of Cardiology conference.

ACC 2012

 Barclays weighs in on TAVI results for Edwards Lifesciences

St. Jude Medical puts more skin in iRhythm Technologies| Acquisitions roundup

May 17, 2011 by MassDevice staff

iRhythm Technologies raises another $15 million, including funds from lead equity round investor St. Jude Medical.

M and A Roundup

St. Jude Medical’s (NYSE:STJ) partnership with a California-based arrhythmia-diagnostic company is going well enough that it recently poured more money into that startup.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp